Howze Yalonda 4

What Happened

• Yalonda Howze, Interim CEO & President of Generation Bio (GBIO), had restricted stock units vest and converted/was issued shares on February 2, 2026. The Form 4 shows conversion/exercise-type entries (code M) and a tax-withholding share disposition (code F). As part of the reported activity, 495 shares were withheld to cover tax liability at $5.64 per share, a total withholding value of $2,792.

Key Details

• Transaction date: February 2, 2026; Form 4 filed February 4, 2026 (timely filing).
• Reported transactions: conversion/exercise of derivative(s) for 1,673 shares (code M) and a tax withholding/disposition of 495 shares at $5.64 each (code F) totaling $2,792. The filing also lists a 1,673-share derivative disposition entry (reported at $0) related to the conversion mechanics.
• Shares owned after transaction: not specified in this filing.
• Footnotes of note:
  • F1: Each restricted stock unit (RSU) represents the right to receive one common share.
  • F2: A grant of 53,550 RSUs made April 5, 2023 vested in full on Feb 2, 2026 due to terms of the merger agreement disclosed in the filing.
• Transaction codes: M = exercise/conversion of derivative (here, conversion of RSUs into shares); F = payment of exercise price or tax liability (shares withheld to cover taxes).

Context

• This was not an open-market purchase or sale for cash; it reflects RSU vesting/conversion and standard tax withholding (a common administrative outcome when equity awards vest).
• The vesting was triggered by the company’s merger agreement (per footnote F2), not a market trade that signals personal buying or selling intentions.